๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen

โœ Scribed by J. G. Kelly; C. D. Kinney; J. G. Devane; S. Mulligan; B. V. Colgan

Book ID
104809011
Publisher
Springer
Year
1989
Tongue
English
Weight
927 KB
Volume
36
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetic analysis of two new sust
Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice-and once-daily treatment
โœ Meir Bialer; Salim Hadad; Gershon Golomb; Shimon Barel; Emil Samara; Omar Abu Sa ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 409 KB ๐Ÿ‘ 2 views

The pharmacokinetics of two new sustained-release (SR) products of diltiazem, Dilapress 120 mg tablets and Dilapress 240 mg tablets, was analysed and characterized in three different studies, in comparison to the following diltiazem SR formulations: Cardizem Retard, Cardizem SR, and Cardizem CD. Dil

Sustained release properties of the once
Sustained release properties of the once daily theophylline capsule BY912 as compared with Theoโ€“24ยฎ capsules
โœ J. H. G. Jonkman; V. W. Steinijans; W. Beier; W. J. V. Van Der Boon; G. Crasmeij ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 422 KB

In a multiple dose cross-over experiment in 12 healthy male adults the bioavailability and sustained release characteristics of new once daily BY912 400 mg theophylline capsules (= B, Byk Gulden Research Laboratories, FRG) were studied using Theo-24@ capsules (= T, Searle & Co., USA) as reference.